During the active phase of the experiment (conducted for 2 months), patients from group A received tamsulosin 0.4 mg/day once and solifenacin at a double dose of 20 mg/day once, patients from group B received tamsulosin 0.4 mg/day and solifenacin in a standard dose of 10 mg/day once, patients from group C received a placebo.
The text above was approved for publishing by the original author.
Basta ir para Caixa de Entrada, clicar no link de confirmação que enviamos e receberá o texto corrigido de volta. Se quiser corrigir mais e-mails, você pode simplesmente:
Ou